DNA甲基化可预测现吸烟者和既往吸烟者的死亡率
研究在COPDGene研究亚组667名现吸烟或既往吸烟者(101例死亡)中检测全血DNA甲基化,发现7个CpG位点与全因死亡率相关(FDR<20%),并在ECLIPSE研究231人中验证(P<0.05)。其中2个PIK3CD位点甲基化与入组时肺功能相关(P<0.05),且与基因表达相关。
要点
- 7个CpG位点甲基化与吸烟者全因死亡率相关并在ECLIPSE验证。
- 2个PIK3CD位点甲基化与入组时肺功能及基因表达相关。
- 外周血表观基因组标记或可用于吸烟者风险分层。
核心结论
- 在现吸烟和既往吸烟者中识别出与全因死亡率相关的差异DNA甲基化位点,并在独立队列验证。
研究设计与样本
- COPDGene研究亚组667名现吸烟或既往吸烟者(含101例死亡),全血DNA甲基化检测,模型校正COPD状态、年龄、性别、当前吸烟状态和包年。
- 在ECLIPSE研究231人中验证。
主要发现
- 7个CpG位点与死亡率相关(FDR<20%)并在ECLIPSE验证(P<0.05)。
- 这些位点与幸存者纵向肺功能下降、吸烟史或当前吸烟状态无关。
- 2个PIK3CD位点差异甲基化与入组时肺功能相关(P<0.05),且与基因表达相关。
关键数值与推荐
- 死亡率相关CpG位点筛选标准:FDR<20%,验证P<0.05。
- PIK3CD位点与入组肺功能关联P<0.05。
临床怎么用
- 评估外周血表观基因组标记可能有助于吸烟者靶向风险分层。
局限性
- 研究聚焦非西班牙裔白人吸烟者,结论外推需谨慎。
- 验证队列样本量较小(231人)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Smoking results in at least a decade lower life expectancy. Mortality among current smokers is two to three times as high as never smokers. DNA methylation is an epigenetic modification of the human genome that has been associated with both cigarette smoking and mortality.Objectives: We sought to identify DNA methylation marks in blood that are predictive of mortality in a subset of the COPDGene (Genetic Epidemiology of COPD) study, representing 101 deaths among 667 current and former smokers.Methods: We assayed genome-wide DNA methylation in non-Hispanic white smokers with and without chronic obstructive pulmonary disease (COPD) using blood samples from the COPDGene enrollment visit. We tested whether DNA methylation was associated with mortality in models adjusted for COPD status, age, sex, current smoking status, and pack-years of cigarette smoking. Replication was performed in a subset of 231 individuals from the ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) study.Measurements and Main Results: We identified seven CpG sites associated with mortality (false discovery rate < 20%) that replicated in the ECLIPSE cohort (P < 0.05). None of these marks were associated with longitudinal lung function decline in survivors, smoking history, or current smoking status. However, differential methylation of two replicated PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta) sites were associated with lung function at enrollment (P < 0.05). We also observed associations between DNA methylation and gene expression for the PIK3CD sites.Conclusions: This study is the first to identify variable DNA methylation associated with all-cause mortality in smokers with and without COPD. Evaluating predictive epigenomic marks of smokers in peripheral blood may allow for targeted risk stratification and aid in delivery of future tailored therapeutic interventions.
引用
- Morrow JD, Make B, Regan E, et al. DNA Methylation Is Predictive of Mortality in Current and Former Smokers. Am J Respir Crit Care Med. 2020. PMID: 31995399. doi:10.1164/rccm.201902-0439OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。